Patent. CN112852714A 【IF: 0】Patent. CN112852714A 2021 May 28 Y-27632 dihydrochloride purchased from AbMole
Patent. WO2021047775A1 【IF: 0】Patent. WO2021047775A1 2021 Mar 18 LY2157299 (Galunisertib) purchased from AbMole
Immune-evasion of KRAS-mutant lung adenocarcinoma mediated by cAMP response element-binding protein 【IF: 0】bioRxiv. 2021 Jun 19;449094 ICG-001 purchased from AbMole
Patent. CN113577057A 【IF: 0】Patent. CN113577057A 2021 Nov 02 Selisistat purchased from AbMole
Patent. CN113249482B 【IF: 0】Patent. CN113249482B 2021 Nov 12 GSK1120212 (Trametinib) purchased from AbMole
Patent. US11154543B2 【IF: 0】Patent. US11154543B2 2021 Oct 26 Losmapimod purchased from AbMole
miR-3587 Targets HMOX1 to Attenuate Ferroptotic Renal Injury Following Ischemia-Reperfusion 【IF: 0】Research Square. 2021 Jul Cell Counting Kit-8 purchased from AbMole
Patent. CN113249482B 【IF: 0】Patent. CN113249482B 2021 Nov 12 Dabrafenib Mesylate purchased from AbMole
Patent. EP3365373B1 【IF: 0】Patent. EP3365373B1 2021 Mar 10 Y-27632 dihydrochloride purchased from AbMole
Patent. CN113249468A 【IF: 0】Patent. CN113249468A 2021 Aug 13 GSK1120212 (Trametinib) purchased from AbMole
Novel Targeted Therapies and Prognostic Markers for T Cell Acute Lymphoblastic Leukemia 【IF: 0】Tampere University. 2021 Azilsartan purchased from AbMole
Patent. CN113186165A 【IF: 0】Patent. CN113186165A 2021 Jul 30 Y-27632 dihydrochloride purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
